Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.01 USD | +8.80% | +6.37% | +19.55% |
09/05 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
08/05 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.55% | 54Cr | |
+7.48% | 11TCr | |
+11.33% | 11TCr | |
-12.32% | 2.22TCr | |
+0.44% | 2.13TCr | |
-4.18% | 1.9TCr | |
-37.85% | 1.85TCr | |
-9.07% | 1.68TCr | |
+38.50% | 1.25TCr | |
-24.30% | 808.97Cr |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- RBC Upgrades IGM Biosciences to Outperform From Sector Perform, Boosts Price Target to $21 From $9; Speculative Risk Kept